glp-1 fda approved for pcos 💊New pill gets approval, and has fewer restrictions on how it's used💊 Wegovy vs Mounjaro: How GLP-1

In a Phase 2 clinical trial published in 2023 in the New England Journal of Medicine (Jastreboff et al.), participants receiving the highest dose of retatrutide lost up to approximately 24% of their body weight over 48 weeks a notably greater reduction than observed with currently approved agents

Medication interactions can occur through several mechanisms: pharmacokinetic interactions (affecting how drugs are absorbed, distributed, metabolised, or excreted) and pharmacodynamic interactions (affecting how drugs work in the body)

These concerns are valid and worth exploring

Conclusion: We describe detailed histopathology in those undergoing LT

At a poster spotlight session at the 2025 San Antonio Breast Cancer Symposium , researchers presented their recent findings on the effects of GLP-1s on people with breast cancer